Kijimea Inc. – An unparalleled success story
Kijimea Inc. is an innovative company based in Toronto, Canada and focused on providing effective help for IBS patients. With KijimeaTM, we’re introducing one of Europe`s best-selling OTC products for IBS to the US market.
Through our vision and passionate leadership, we strive to become the main provider of products for the management of IBS in the US. It goes without saying that we always maintain the highest quality standards.
Speed to market
Due to our company’s flat hierarchies, our work is characterized by a high level of flexibility and speed in decision-making processes. This enables us to rapidly respond to the latest needs and continuously set our own momentum – both of which are decisive factors for our competitiveness around the world!
We also set ourselves apart by another quality: We don’t just think from an entrepreneurial point of view, we also act in an entrepreneurial manner. And to us this means constantly reinventing ourselves, allowing room for innovative ideas, and having the courage to implement them.
Clemens Fischer founder of Kijimea Inc., is a Harvard University MBA graduate who also holds a doctorate in medicine and a Business Economics degree. He is a serial entrepreneur that has founded numerous companies, many of which he sold after successfully positioning them in the market; amongst the buyers are pharmaceutical giants such as Novartis, Dermapharm, and Perrigo. Before establishing his own pharmaceutical company, Clemens Fischer worked for companies such as Novartis, where he was a member of the German executive board and was responsible for the Strategy and Cardiovascular divisions.